within
phospholipas
pla
famili
hydrolyz
phospholipid
yield
fatti
acid
lysophospholipid
secret
pla
spla
enzym
compris
largest
group
contain
isoform
mammal
individu
spla
exhibit
uniqu
tissu
cellular
distribut
enzymat
properti
suggest
distinct
biolog
role
although
pla
enzym
particularli
cytosol
pla
cpla
long
implic
inflamm
drive
arachidon
acid
metabol
precis
biolog
role
spla
remain
mysteri
last
decad
recent
studi
employ
mice
genemanipul
individu
spla
combin
mass
spectrometr
lipidom
identifi
target
substrat
product
vivo
reveal
role
divers
biolog
event
includ
immun
associ
disord
lipid
mediatordepend
independ
process
given
microenviron
review
summar
current
knowledg
role
spla
variou
immun
respons
associ
diseas
spla
immun
gener
aspect
spla
pla
enzym
group
enzym
hydrolyz
posit
phospholipid
yield
fatti
acid
lysophospholipid
fig
onethird
pla
enzym
belong
spla
famili
contain
catalyt
activ
isoform
ib
iia
iic
iid
iie
iif
iii
v
x
xiia
inact
isoform
xiib
mammal
denni
cao
hsu
magrioti
kokoto
lambeau
gelb
murakami
sato
miki
yamamoto
taketomi
murakami
taketomi
miki
et
al
convent
spla
group
iiivx
close
relat
enzym
highli
conserv
ca
bind
loop
hisasp
catalyt
dyad
well
conserv
disulfid
bond
atyp
spla
group
iii
xii
classifi
distinct
collect
fig
evolut
group
ib
spla
oldest
convent
spla
anim
kingdom
sinc
three
iblik
gene
present
c
elegan
group
ii
v
x
spla
exist
vertebr
murakami
taketomi
miki
et
al
group
iii
spla
present
vertebr
insect
conserv
group
xii
spla
bacteria
human
suggest
emerg
earli
evolut
prior
eubacteria
nevalainen
cardoso
group
ix
xi
xiii
xiv
spla
present
invertebr
plant
virus
fungi
respect
vertebr
tissu
cellular
distribut
stimulu
induc
individu
spla
distinct
fig
suggest
differ
biolog
role
spla
secret
requir
millimolar
ca
catalysi
act
essenti
extracellular
phospholipid
includ
adjac
cell
membran
microparticl
surfact
lipoprotein
foreign
lipid
food
microorgan
respons
microenvironment
cue
biochem
analys
shown
individu
spla
distinct
substrat
select
term
polar
head
group
fatti
acid
phospholipid
regard
polar
head
group
group
ii
spla
show
prefer
phosphatidylethanolamin
pe
phosphatidylcholin
pc
activ
pc
prefer
partli
explain
term
crystal
structur
pan
et
al
scott
et
al
regard
fatti
acid
distinguish
fatti
acid
speci
prefer
fatti
acid
lower
degre
unsatur
eg
oleic
acid
oa
show
prefer
polyunsatur
fatti
acid
pufa
arachidon
acid
aa
docosahexaeno
acid
dha
variou
degre
chen
denni
chen
engl
seilham
tischfield
cupillard
koumanov
mattei
lazdunski
lambeau
guillaum
et
al
hanasaki
et
al
miki
et
al
mitsuishi
masuda
kudo
murakami
murakami
et
al
muras
et
al
pruzanski
et
al
sato
et
al
yamamoto
et
al
although
substrat
specif
spla
differ
accord
vitro
assay
condit
employ
particularli
excess
amount
enzym
use
overal
tendenc
recapitul
sever
vivo
system
often
even
select
pattern
hydrolysi
may
affect
phospholipid
composit
target
membran
classif
biochem
cell
biolog
featur
spla
detail
recent
review
denni
et
al
lambeau
gelb
murakami
lambeau
murakami
et
al
murakami
taketomi
girard
yamamoto
lambeau
murakami
taketomi
miki
et
al
murakami
et
al
murakami
taketomi
sato
yamamoto
chapter
highlight
vivo
function
associ
lipidmetabol
action
spla
context
immun
relat
diseas
reveal
studi
use
transgen
tg
andor
knockout
ko
mice
combin
sophist
lipidom
approach
reveal
vivo
lipid
substrat
metabolit
potenti
role
spla
lesson
spla
transgen
mice
biolog
action
spla
vivo
address
use
spla
overexpress
tg
mice
provid
inform
insight
potenti
pathophysiolog
role
spla
aitoufella
et
al
cash
kuhel
goodin
hui
curf
et
al
grass
et
al
ivand
et
al
lain
grass
nevalainen
mulherkar
et
al
ohtsuki
et
al
sato
et
al
sato
et
al
sato
et
al
taketomi
et
al
yamamoto
et
al
yamamoto
et
al
section
briefli
summar
gener
aspect
rather
describ
individu
topic
detail
spla
tg
mice
noteworthi
spla
tg
mice
develop
inflammatori
phenotyp
argu
current
assumpt
spla
gener
particip
inflamm
produc
proinflammatori
eicosanoid
ie
aa
metabolit
includ
prostaglandin
pg
leukotrien
lt
critic
overal
phenotyp
tg
mice
differ
spla
entir
ident
differ
spla
similar
enzymat
properti
result
phenotyp
mice
tg
would
expect
similar
actual
case
like
explan
individu
spla
distinct
enzymat
properti
act
differ
phospholipid
substrat
mobil
differ
lipid
metabolit
vivo
instanc
mice
display
neonat
death
due
lung
collaps
wherea
tg
mice
spla
show
lethal
phenotyp
grass
et
al
ohtsuki
et
al
sato
et
al
yamamoto
et
al
like
compar
spla
potent
activ
dipalmitoylpc
major
surfact
phospholipid
vivo
condit
tg
mice
certain
spla
display
particular
phenotyp
opposit
ko
mice
defici
spla
emphas
phenotyp
reflect
intrins
function
given
spla
case
tg
mice
use
screen
potenti
substrat
product
driven
enzym
vivo
sinc
lipid
mobil
spla
tg
mice
typic
larg
easi
monitor
use
lipidom
approach
subsequ
section
exampl
find
present
howev
result
obtain
tg
mice
interpret
caution
sinc
superphysiolog
level
spla
even
tissu
cell
enzym
express
endogen
could
result
artifici
phenotyp
exampl
alopecia
hair
loss
observ
mice
grass
et
al
yamamoto
et
al
despit
fact
endogen
express
spla
mous
skin
low
undetect
fact
artifici
overexpress
skin
spla
mimic
intrins
action
major
spla
endogen
express
epidermi
see
later
furthermor
mice
exhibit
distinct
skin
phenotyp
manifest
ageassoci
spontan
inflamm
sato
et
al
wherea
tg
mice
spla
show
notic
skin
abnorm
unpublish
result
observ
impli
differ
spla
distinct
enzymat
properti
hydrolyz
differ
phospholipid
mobil
differ
lipid
product
vivo
group
iia
spla
spla
iia
prototyp
spla
whose
level
sera
inflammatori
exud
posit
correl
sever
inflammatori
diseas
eg
rheumatoid
arthriti
sepsi
cardiovascular
diseas
kugiyama
et
al
pruzanski
vada
stefanski
urowitz
express
spla
isoform
markedli
induc
proinflammatori
stimuli
lp
wide
varieti
cell
tissu
variou
anim
speci
includ
human
crowl
stoller
conroy
stoner
kuwata
nakatani
murakami
kudo
nakano
ohara
teraoka
arita
spla
isoform
detect
blood
circul
particularli
inflammatori
condit
mice
howev
express
highli
restrict
intestin
eg
balbc
strain
express
due
natur
frameshift
mutat
eg
strain
kennedi
et
al
macphe
et
al
situat
hinder
precis
assess
physiolog
function
standard
genetarget
strategi
strain
gener
use
therefor
recent
vivo
function
address
mainli
use
tg
mice
low
affin
pc
mention
earlier
hardli
hydrolyz
phospholipid
quiescent
mammalian
cell
act
directli
outer
leaflet
plasma
membran
pc
rich
instead
effici
hydrolyz
phospholipid
bacteri
membran
pe
rich
inde
kill
bacteria
gramposit
particular
physiolog
concentr
vitro
addit
substrat
prefer
highli
cation
natur
share
spla
also
critic
bacteri
kill
enzym
koprivnjak
peschel
gelb
liang
weiss
weiss
inada
elsbach
crowl
inde
highli
express
exocrin
gland
intestin
paneth
cell
tear
gland
qu
lehrer
continu
expos
environment
bacteria
moreov
mice
wt
mice
treat
show
resist
sepsi
pneumonia
follow
bacteri
infect
lain
et
al
lain
grass
nevalainen
movert
wu
lambeau
touqui
areschoug
pernet
et
al
pirisgimenez
et
al
henc
gener
accept
play
import
role
host
defens
bactericid
spla
bacteria
pseudomona
aeruginosa
bacillu
anthraci
escap
bactericid
action
suppress
induct
macrophag
pernet
et
al
raymond
et
al
releas
induc
proinflammatori
stimuli
variou
immun
cell
specul
spla
might
play
role
inflamm
yet
definit
evid
hypothesi
lack
last
decad
number
cellbas
studi
shown
overexpress
ad
exogen
high
concentr
capabl
releas
aa
cytokineprim
apoptot
cell
prefer
substrat
pe
phosphatidylserin
ps
might
expos
outer
leaflet
plasma
membran
koduri
et
al
murakami
et
al
howev
unclear
whether
system
fact
oper
vivo
recent
concept
act
driver
steril
inflamm
examin
seri
studi
boilard
colleagu
backcross
mutat
allel
strain
onto
balbc
strain
produc
balbc
mice
mice
protect
autoantibodyinduc
arthriti
model
rheumatoid
arthriti
wherea
mice
suscept
arthriti
model
boilard
et
al
complementari
result
obtain
use
ko
tg
mice
strongli
support
proinflammatori
role
furthermor
boilard
colleagu
elegantli
shown
hydrolyz
phospholipid
microparticl
particularli
extracellular
mitochondria
type
organel
evolut
origin
bacteria
releas
activ
platelet
leukocyt
inflam
site
boudreau
et
al
hydrolyt
breakdown
mitochondri
microparticular
membran
give
rise
inflammatori
mediat
includ
eicosanoid
lysophospholipid
well
mitochondri
dna
damp
dangerassoci
molecular
pattern
promot
leukocyt
activ
moreov
extracellular
mitochondria
microparticl
interact
neutrophil
allow
adhes
vascular
wall
hydrolysi
microparticl
result
product
acid
hete
aa
metabolit
act
receptor
amplifi
cytokin
product
cpla
ltb
gener
neutrophil
therebi
lead
acceler
steril
inflamm
duchez
et
al
breakthrough
find
account
longsought
mechan
role
inflammatori
spla
thu
like
primarili
involv
host
defens
kill
bacteria
trigger
innat
immun
wherea
overamplif
respons
lead
inflamm
fig
chronic
inflamm
pose
potenti
risk
develop
cancer
express
correl
posit
prostat
lung
breast
cancer
brglez
lambeau
petan
graff
et
al
scott
et
al
chronic
inflamm
induc
might
contribut
promot
cancer
inde
pg
lt
potenti
downstream
lipid
mediat
pla
involv
cancer
develop
chen
hu
zhang
peng
li
nakanishi
et
al
hand
mous
strain
intrins
lack
suscept
intestin
tumorigenesi
macphe
et
al
tg
express
intact
gene
mice
strain
mutat
allel
revers
phenotyp
cormier
et
al
indic
antitumor
effect
gastrointestin
gi
tract
consist
gene
polymorph
gene
associ
fig
biolog
role
host
defens
inflamm
induc
secret
immun
cell
eg
macrophag
platelet
respons
proinflammatori
stimuli
eg
pattern
pamp
danger
damp
associ
molecular
pattern
hydrolyz
bacteri
membran
phospholipid
elimin
bacteria
therebi
play
key
role
antibacteri
host
defens
also
contribut
augment
product
proinflammatori
lipid
mediat
cytokin
act
phospholipid
microparticl
extracellular
mitochondria
therebi
amplifi
inflamm
fundic
gland
polyposi
patient
famili
adenomat
polyposi
tomlinson
beck
neal
bodmer
express
invers
correl
incid
gastric
cancer
human
leung
et
al
although
present
mechan
underli
antitumor
role
gi
tract
remain
unclear
specul
bactericid
spla
secret
intestin
paneth
cell
colorect
epitheli
cell
may
alter
intestin
microbiota
therebi
affect
tumor
develop
atherosclerosi
character
lowgrad
chronic
inflamm
arteri
wall
inflammatori
spla
long
believ
biomark
possibl
effector
atherosclerosi
serum
level
show
posit
correl
cardiovascular
diseas
kugiyama
et
al
gene
polymorph
associ
atherosclerosi
wootton
et
al
support
mice
ldlr
mice
harbor
adopt
transfer
bone
marrow
cell
develop
advanc
atherosclerot
lesion
ivand
et
al
webb
et
al
howev
sinc
superphysiolog
level
spla
tg
mice
often
result
artifici
phenotyp
mention
earlier
conclus
evid
aggrav
role
atherosclerosi
await
futur
studi
use
mice
suitabl
genet
background
discuss
potenti
role
spla
atherosclerosi
subsequ
section
spla
iid
structur
similar
valentin
koduri
et
al
express
preferenti
secondari
lymphoid
organ
spleen
lymph
node
ln
fig
enrich
dendrit
cell
dc
miki
et
al
among
dc
subset
lymphoid
organ
express
abundantli
dc
assist
humor
immun
gener
albeit
lower
level
also
express
tissueresid
dc
eg
dermal
pulmonari
dc
inflammatori
dc
regulatori
cell
miki
et
al
vijay
et
al
von
allmen
et
al
express
decreas
dc
activ
miki
et
al
phospholipid
extract
ln
use
substrat
preferenti
hydrolyz
pe
aa
dha
tendenc
prefer
latter
miki
et
al
properti
consist
antiinflammatori
role
describ
later
model
contact
hypersensit
ch
applic
hapten
antigen
dinitrofluorobenzen
dnfb
abdomin
skin
sensit
follow
second
applic
antigen
ear
skin
elicit
induc
ear
swell
elicit
phase
resolut
propag
inflamm
skin
ln
delay
mice
miki
et
al
region
ln
level
pufa
includ
aa
dha
well
antiinflammatori
product
includ
resolvin
respect
reduc
mice
rel
wt
mice
reduct
latter
promin
fig
togeth
substrat
select
describ
earlier
appear
preferenti
hydrolyz
aaor
dhabear
pe
ln
membran
like
microparticl
therebi
mobil
aaor
dhaderiv
antiinflammatori
lipid
mediat
latter
particular
dampen
adapt
immun
fig
inde
pufaderiv
resolvin
suppress
acquir
immun
dampen
dc
migrat
antigen
present
cell
sawada
et
al
furthermor
administr
fusion
protein
mice
prevent
experiment
autoimmun
encephalomyel
coliti
von
allmen
et
al
thu
resolv
spla
amelior
dccommit
innat
adapt
immun
respons
mobil
antiinflammatori
lipid
mediat
knowledg
first
exampl
particular
spla
mobil
dha
metabolit
vivo
oxid
stress
chronic
lowgrad
inflamm
lung
associ
age
contribut
agerel
immun
dysfunct
whose
express
lung
dc
increas
age
respons
prolong
exposur
oxid
stress
contribut
wors
outcom
mice
infect
sever
acut
respiratori
syndromecoronaviru
influenza
viru
vijay
et
al
mice
resist
infectioninduc
death
accompani
enhanc
migrat
lung
reduct
dha
level
drain
ln
mice
compar
mice
day
second
challeng
dnfb
ch
model
n
mean
ae
sem
p
b
schemat
model
antiinflammatori
role
ch
express
dc
ln
hydrolyz
pe
releas
pufa
particularli
dha
metabol
block
proinflammatori
immun
respons
ag
antigen
c
role
antivir
immun
lung
dc
produc
pgd
prevent
dc
migrat
ln
therebi
suppress
tcell
activ
accordingli
attenu
antivir
immun
increas
viral
infect
dc
drain
ln
augment
antiviru
tcell
respons
decreas
lung
injuri
case
respons
pulmonari
mobil
pgd
act
antiinflammatori
receptor
dampen
dc
migrat
therebi
tcelldriven
antiviru
respons
fig
accordingli
attenu
antivir
immun
mice
result
sever
lung
inflamm
earli
death
thu
direct
inhibit
lung
older
patient
sever
respiratori
infect
would
potenti
attract
therapeut
intervent
restor
immun
function
spla
iif
structur
featur
group
ii
spla
possess
extra
ctermin
sequenc
uniqu
cy
residu
valentin
ghomashchi
gelb
lazdunski
lambeau
unlik
spla
activ
neutral
alkalin
ph
rang
fulli
activ
mildli
acid
ph
properti
appear
import
role
mildli
acid
environ
suprabas
epidermi
spla
express
predominantli
fig
ilic
bolling
gelb
mauro
yamamoto
et
al
select
hydrolyz
dhacontain
plasmalogenp
ppe
skinextract
phospholipid
yield
dha
plasmalogenlysophosphatidylethanolamin
plpe
physiolog
concentr
also
hydrolyz
lipoprotein
phospholipid
releas
pufa
vitro
turn
prevent
vitro
growth
malaria
parasit
plasmodium
falciparum
infect
erythrocyt
guillaum
et
al
howev
lipoproteinhydrolyt
antimalaria
action
need
confirm
vivo
express
termin
differenti
keratinocyt
suprabas
epidermi
markedli
increas
hyperplas
epidermi
mice
skin
diseas
model
patient
psoriasi
global
skinspecif
mice
spontan
develop
epiderm
hyperplasia
alopecia
increas
express
sever
psoriasi
marker
fig
although
mice
exhibit
mild
skin
abnorm
basal
state
character
fragil
stratum
corneum
modest
perturb
skin
barrier
function
acid
primari
keratinocyt
isol
null
mice
show
defect
ca
induc
differenti
activ
show
mice
spontan
develop
psoriasislik
epiderm
hyperplasia
hair
loss
skin
express
psoriasisassoci
gene
markedli
increas
tg
skin
compar
wt
skin
n
bottom
b
schemat
model
role
psoriasi
induc
cell
hydrolyz
extracellular
ppe
releas
keratinocyt
give
rise
plpe
promot
keratinocyt
activ
lead
psoriat
epiderm
hyperplasia
inflamm
c
aggrav
skin
cancer
mice
carcinogenesi
model
gross
appear
left
monitor
tumor
number
n
right
wt
tg
mice
shown
mean
ae
sem
p
p
import
skin
pathophysiolog
highlight
mice
subject
skin
diseas
model
psoriasi
one
common
chronic
skin
diseas
western
countri
character
epiderm
hyperplasia
acanthosi
scale
erythemat
plaqu
format
due
aberr
prolifer
differenti
activ
keratinocyt
well
infiltr
activ
immun
cell
cytokineproduc
lymphocyt
low
suarezfarina
krueger
strikingli
mice
protect
epiderm
hyperplasia
model
psoriasi
ch
former
model
express
keratinocyt
upregul
lesser
extent
primari
keratinocyt
express
sever
psoriasi
marker
markedli
impair
mechanist
hydrolyz
ppe
secret
keratinocyt
yield
plpe
uniqu
lysophospholipid
acceler
differenti
activ
keratinocyt
lead
propag
skin
inflamm
fig
find
provid
first
vivo
evid
particular
spla
regul
biolog
process
mobil
lysophospholipid
mediat
skinspecif
mice
sensit
chemic
carcinogenesi
mulherkar
et
al
although
express
endogen
mous
skin
mice
also
suscept
skin
carcinogenesi
model
appar
propens
develop
larger
tumor
wt
mice
fig
convers
mice
highli
protect
develop
skin
tumor
accompani
lower
product
plpe
unalt
product
canon
aa
metabolit
collect
result
highlight
fact
bona
fide
epiderm
spla
promot
skin
inflamm
cancer
plpe
biomark
bioactiv
lipid
reflect
express
function
artifici
overexpress
mous
skin
may
mimic
intrins
patholog
action
group
iii
spla
spla
iii
atyp
spla
similar
bee
venom
group
iii
spla
mammalian
spla
central
spla
domain
typic
group
iii
featur
flank
uniqu
nand
ctermin
domain
nand
ctermin
domain
remov
give
rise
matur
spla
domainonli
form
discrimin
phospholipid
polar
head
group
fatti
acid
modest
tendenc
prefer
pufa
includ
linol
acid
la
aa
dha
abl
augment
releas
aa
transfect
cell
murakami
et
al
lipoprotein
sato
et
al
much
effici
group
ii
spla
member
vitro
properti
might
relat
role
atyp
spla
vivo
describ
later
mast
cell
known
plastic
environment
induc
alter
mast
cell
phenotyp
could
affect
sever
immedi
hypersensit
anaphylaxi
gurish
austen
rivera
fierro
olivera
suzuki
crosslink
highaffin
ige
receptor
mast
cell
ige
antigen
initi
signal
lead
releas
allerg
mediat
histamin
eicosanoid
induc
allerg
inflamm
activ
mast
cell
produc
pgd
ltb
ltc
main
eicosanoid
accumul
evid
suggest
mast
cellderiv
ltb
ltc
exacerb
pgd
amelior
allerg
diseas
kanaoka
maekawa
penros
austen
lam
nakamura
et
al
ott
cambier
kappler
marrack
swanson
taketomi
et
al
initi
aa
metabol
mast
cell
depend
sole
cpla
aaselect
intracellular
pla
upon
signal
activ
mitogenactiv
protein
kinas
undergo
ca
depend
transloc
cytosol
perinuclear
membran
downstream
eicosanoidbiosynthet
enzym
resid
clark
et
al
lin
et
al
ueno
et
al
allerg
respons
asthma
attenu
mice
lack
cpla
treat
cpla
inhibitor
malaviya
et
al
uozumi
et
al
howev
role
spla
allergi
context
mast
cell
biolog
vivo
remain
elus
last
decad
bee
venom
group
iii
pla
inject
mous
skin
activ
mast
cell
hydrolysi
membran
phospholipid
releas
lysophosphatidylcholin
lpc
caus
cell
lysi
lead
activ
group
innat
lymphoid
cell
releas
cytokin
palm
et
al
exogen
human
also
facilit
mast
cell
activ
mous
skin
endogen
store
releas
mous
mast
cell
granul
importantli
mast
celldepend
passiv
activ
anaphylact
respons
markedli
attenu
mice
convers
augment
mice
phenotyp
mast
cell
autonom
bone
marrowderiv
mast
cell
mice
fail
reconstitut
anaphylact
respons
transfer
mast
celldefici
kit
wshwsh
mice
notabl
mast
cell
mice
numer
normal
morpholog
function
immatur
indic
mere
act
mast
cell
activ
also
facilit
mast
cell
matur
moreov
mast
cell
abnorm
observ
mice
recapitul
mice
lack
lipocalintyp
pgd
synthas
lpgd
express
neighbor
fibroblast
lack
pgd
receptor
induc
matur
mast
cell
pharmacolog
genet
ablat
mast
cell
lpgd
fibroblast
phenocopi
mast
cell
term
perturb
mast
cell
matur
anaphylaxi
thu
secret
mast
cell
coupl
fibroblast
lpgd
produc
microenvironment
pgd
act
mast
cell
promot
proper
matur
fig
event
also
applic
human
mast
cell
none
spla
test
far
affect
anaphylaxi
highlight
specif
role
anaphylact
spla
paracrin
circuit
highlight
new
aspect
pgd
signal
regul
mast
cell
matur
therebi
allergi
provid
solid
vivo
evid
spla
act
paracrin
coordin
eicosanoid
product
tissu
microenviron
starkl
marich
galli
taketomi
et
al
remain
question
answer
whether
mast
cellsecret
would
target
phospholipid
plasma
membran
adjac
fibroblast
microparticl
shed
mast
cell
tg
overexpress
apo
mice
result
increas
atherosclerosi
due
acceler
lipoprotein
hydrolysi
increas
thromboxan
synthesi
sato
et
al
mice
also
develop
system
inflamm
age
probabl
due
increas
eicosanoid
gener
sato
et
al
furthermor
colon
cancer
cell
increas
tumorigen
transplant
nude
mice
sever
line
evid
suggest
posit
correl
human
colon
cancer
hoeft
et
al
kazama
et
al
mounier
et
al
thu
beyond
overexpress
strategi
appear
proatherogen
proinflammatori
protumorigen
potenti
apart
immunolog
aspect
mice
display
male
infertil
due
impair
epididym
sperm
motil
matur
sato
et
al
mechanist
secret
epididym
epitheli
cell
act
spermatozoa
pass
epididym
duct
promot
membran
phospholipid
remodel
allow
enrich
docosapentaeno
acid
dpa
dha
sperm
membran
phospholipid
recent
function
genom
screen
identifi
neg
regul
ciliogenesi
kim
et
al
product
fig
biolog
role
mast
cell
matur
anaphylaxi
secret
immatur
mast
cell
coupl
fibroblast
lpgd
produc
microenvironment
pool
pgd
act
pgd
receptor
immatur
mast
cell
facilit
function
matur
matur
mast
cell
express
higher
level
cpla
hpgd
upon
crosslink
ige
antigen
produc
distinct
larg
pool
pgd
attenu
allerg
respons
lysophospholipid
whose
express
upregul
transcript
factor
lead
distort
endosom
recycl
vesicular
traffick
ciliogenesi
gij
et
al
primari
cilium
microtubulebas
organel
project
surfac
wide
varieti
cell
act
antenna
sens
extracellular
cue
regul
divers
signal
pathway
berbari
oconnor
haycraft
yoder
christensen
pedersen
schneider
satir
defect
cilium
format
recogn
central
event
mani
type
patholog
state
includ
classic
ciliopathi
obes
cancer
fliegauf
benz
omran
sen
gupta
prodrom
chappl
consid
could
affect
inflamm
cancer
sperm
flagellar
motil
see
earlier
regul
ciliogenesi
might
common
mechan
underli
function
sever
pathophysiolog
event
spla
v
often
classifi
group
ii
subfamili
spla
sinc
gene
map
group
ii
spla
cluster
locu
even
though
possess
key
featur
group
ii
spla
chen
engl
seilham
tischfield
tischfield
et
al
hydrolyz
pc
effici
group
ii
spla
han
et
al
lead
propos
spla
may
particip
inflamm
drive
aa
metabol
pcrich
mammalian
cell
membran
howev
obviou
releas
fatti
acid
low
degre
unsatur
oa
la
favor
aa
cellular
membran
lipoprotein
phospholipid
vesicl
chen
denni
chen
et
al
mitsuishi
et
al
murakami
et
al
pruzanski
et
al
therefor
may
drive
type
lipid
metabol
addit
even
unrel
canon
aa
metabol
exert
biolog
action
vivo
inde
neonat
death
mice
aris
abil
enzym
hydrolyz
lung
surfact
pc
satur
monounsatur
fatti
acid
ie
palmit
acid
palmitol
acid
independ
eicosanoid
gener
ohtsuki
et
al
describ
later
recent
eleg
studi
reveal
uniqu
featur
modul
immun
spla
metabol
disord
metabol
spla
among
other
fig
line
classic
idea
note
earlier
initi
studi
use
mice
show
modestli
augment
zymosaninduc
periton
lpsinduc
air
pouch
inflamm
lapoint
et
al
satak
et
al
howev
subsequ
studi
pioneer
arm
cowork
shown
sever
situat
exert
antiinflammatori
fig
biolog
role
immun
metabol
syndrom
role
immun
phagocytosi
preferenti
express
macrophag
promot
phagocytosi
antigen
uptak
macrophag
dendrit
cell
possibl
product
lpe
also
facilit
skew
antigenpres
cell
although
mechan
account
function
remain
unclear
immun
associ
asthma
wherea
counteract
immun
respons
b
predomin
spla
isozym
express
heart
femal
mice
feed
lowfat
diet
lfd
highfat
diet
hfd
week
c
express
metabol
activ
tissu
femal
mice
week
lfd
note
express
wat
well
heart
highli
induc
hfd
feed
see
text
metabol
role
induc
adipocyt
obes
hydrolyz
pc
ldl
releas
oleat
linol
counteract
palmitateinduc
adipos
tissu
inflamm
therebi
obesityassoci
metabol
disord
pa
palmit
acid
function
may
reli
common
mechan
involv
regul
macrophag
phagocytosi
spla
periton
macrophag
mice
show
reduc
phagocytosi
fungi
yeast
candida
albican
ex
vivo
mice
display
sever
system
candidiasi
higher
mortal
due
increas
fungal
burden
multipl
tissu
vivo
balestrieri
et
al
balestrieri
et
al
regard
contribut
antifung
innat
immun
facilit
phagocytot
kill
likewis
increas
airway
inflamm
mice
escherichia
coli
infect
could
explain
part
reduc
clearanc
bacterium
alveolar
macrophag
degouse
et
al
arthriti
also
exacerb
mice
opsonizationdriven
clearanc
pathogen
immun
complex
macrophag
hamper
boilard
et
al
exogen
supplement
adenovir
transfer
mice
rescu
candida
clearanc
amelior
arthriti
facilit
macrophag
phagocytosi
fungi
immun
complex
respect
conceiv
oppos
function
protect
promot
arthriti
respect
could
explain
panspla
inhibitor
fail
exert
therapeut
effect
rheumatoid
arthriti
clinic
studi
bradley
et
al
potenti
mechan
regul
phagocytosi
may
produc
fusogen
lysophospholipid
membran
microdomain
fusion
occur
plasma
membran
phagosom
membran
line
idea
recent
shown
may
facilit
phagocytosi
human
macrophag
product
lpe
rubio
et
al
altern
may
affect
polar
macrophag
therebi
influenc
phacocytot
capac
see
later
express
lung
elev
patient
asthma
mice
subject
asthma
model
local
bronchial
epitheli
cell
alveolar
macrophag
munoz
et
al
mice
protect
antigeninduc
asthma
lpsor
ventilatorinduc
alveolar
injuri
giannattasio
et
al
henderson
et
al
meliton
et
al
munoz
et
al
munoz
meliton
meliton
dudek
leff
ohta
imamura
xing
boyc
balestrieri
indic
act
proinflammatori
enzym
airway
bone
marrow
transfer
experi
reveal
antigenpres
cell
promot
antigen
uptak
therebi
antigen
present
cell
elicit
respons
airway
epitheli
cell
augment
lung
injuri
probabl
surfact
degrad
giannattasio
et
al
henderson
et
al
ohta
et
al
ohtsuki
et
al
importantli
spla
isoform
induc
cytokin
macrophag
cell
promot
immun
respons
facilit
express
ige
product
ln
cell
ohta
et
al
rubio
et
al
sato
et
al
inde
express
macrophag
suffici
develop
asthma
induc
hous
dust
mite
ohta
et
al
properti
spla
appear
fit
view
mice
protect
asthma
depend
giannattasio
et
al
munoz
et
al
wherea
suffer
sever
infect
depend
arthriti
depend
balestrieri
et
al
boilard
et
al
immun
counterbalanc
immun
immun
balanc
regul
toward
state
could
thu
explain
enzym
exhibit
proor
antiinflammatori
action
depend
distinct
diseas
context
notion
may
also
true
metabol
role
describ
later
role
phagocytosi
immun
illustr
fig
incid
metabol
syndrom
increas
explos
rate
worldwid
due
pandem
obes
type
diabet
result
over
highcalor
food
despr
lemieux
mechan
connect
insulin
resist
obes
includ
elev
circul
lipid
ectop
lipid
deposit
lead
lipotox
chronic
inflamm
metabol
activ
tissu
hotamisligil
among
spla
highli
induc
hypertroph
adipocyt
obes
mice
fact
along
constitut
express
rel
high
level
heart
high
demand
lipid
energi
sourc
fig
suggest
regul
energi
metabol
may
one
primari
role
spla
level
express
wat
heart
markedli
elev
age
mice
rel
young
mice
fig
perhap
reflect
upregul
agerel
obes
andor
unknown
mechan
highfat
diet
hfd
mice
display
sever
metabol
disord
increas
obes
hepat
steatosi
elev
level
plasma
lowdens
lipoprotein
ldl
level
exacerb
insulin
resist
mechanist
protect
metabol
disord
normal
lipid
content
fatoverladen
ldl
tip
immun
balanc
toward
state
counterregul
adipos
tissu
inflamm
unsatur
fatti
acid
oa
la
releas
pc
hyperlipidem
ldl
adipocytedriven
prevent
polar
adipos
tissu
macrophag
palmit
acid
satur
fatti
acid
promot
metabol
inflamm
moreov
agreement
role
macrophag
phagocytosi
see
earlier
might
result
alter
macrophag
ratio
hfdfed
mice
show
impair
clearanc
dead
cell
adipos
tissu
overal
allow
adipos
tissu
antiinflammatori
state
regul
balanc
detriment
satur
fatti
acid
benefici
unsatur
fatti
acid
addit
given
immun
counteract
metabol
diseas
odegaard
chawla
reduc
wholebodi
statu
mice
see
earlier
may
also
underli
exacerb
metabol
outcom
result
reveal
physiolog
import
lipoprotein
hydrolysi
spla
highlight
metabol
spla
integr
regul
metabol
inflamm
metabol
regul
illustr
fig
note
express
human
adipos
tissu
invers
correl
plasma
ldl
level
mutat
associ
ldl
level
patient
type
diabet
obes
sergounioti
et
al
wootton
et
al
impli
relev
find
human
prior
discoveri
role
metabol
spla
describ
earlier
enzym
long
implic
atherosclerosi
scenario
spla
mediat
hydrolysi
ldl
give
rise
type
proatherogen
smalldens
ldl
increas
net
neg
charg
lpc
content
aggreg
propens
hanasaki
et
al
wootonke
boyanovski
nasser
de
villier
webb
treatment
ldl
sever
spla
x
v
iii
iif
iia
rank
order
facilit
hydrolysi
phospholipid
therebi
format
lipidladen
foam
cell
macrophag
vitro
boyanovski
van
der
westhuyzen
webb
hanasaki
et
al
sato
et
al
hallmark
featur
atherosclerosi
howev
vivo
relev
phenomenon
remain
controversi
ldlr
mice
transfer
bone
marrow
cell
modestli
protect
atherosclerosi
bostrom
et
al
wherea
global
defici
apo
background
affect
plaqu
format
boyanovski
zack
forrest
webb
although
former
studi
suggest
hematopoiet
probabl
macrophag
contribut
partial
atherosclerosi
develop
plasma
ldl
level
unaffect
ablat
case
argu
propos
role
ldl
metabol
atherosclerot
condit
contradictori
result
also
report
role
cardiac
disord
ablat
aggrav
cardiac
fibrosi
boyanovski
bailey
dixon
shrida
webb
wherea
convers
attenu
myocardi
infarct
aneurysm
boyanovski
et
al
yano
et
al
moreov
panspla
inhibitor
fail
show
efficaci
phase
iii
clinic
trial
context
cardiovascular
diseas
nichol
et
al
thu
convent
spla
may
contribut
significantli
atherosclerosi
relat
cardiovascular
disord
even
though
may
promot
suppress
certain
condit
rather
ldl
hydrolysi
appear
relev
obesityrel
metabol
syndrom
describ
earlier
group
x
spla
spla
x
group
iand
group
iilik
structur
featur
suggest
emerg
diversif
group
ii
spla
cupillard
et
al
case
see
later
synthes
zymogen
remov
ntermin
propeptid
produc
activ
matur
enzym
process
may
occur
extracellularli
secret
case
mani
digest
enzym
gi
tract
intracellularli
secret
furinlik
convertas
jemel
et
al
layn
shrida
webb
masuda
et
al
among
spla
highest
affin
pc
thu
exhibit
potent
abil
hydrolyz
plasma
membran
phospholipid
intact
cell
bezzin
et
al
murakami
et
al
properti
mani
studi
perform
assumpt
play
proinflammatori
role
mobil
aa
metabol
notion
may
inde
correct
situat
draw
attent
sever
import
aspect
enzym
appear
forgotten
ignor
mani
investig
first
tissu
distribut
ubiquit
express
almost
exclus
gi
tract
testi
much
lesser
extent
lung
fig
least
mice
express
rel
sever
spla
fairli
low
undetect
immun
cell
cours
exclud
possibl
express
immun
cell
popul
certain
condit
notion
enzym
express
wide
immun
cell
play
immunoregulatori
role
appar
mislead
need
reassess
care
second
power
spla
hydrolysi
cellular
membran
capabl
releas
aa
cell
type
even
cell
intrins
express
suppli
artifici
henc
even
cell
capabl
releas
aa
robustli
would
necessarili
reflect
physiolog
function
third
show
appar
pufa
prefer
releas
pufa
epa
dpa
dha
addit
even
preferenti
aa
cultur
cell
lipoprotein
even
tissu
muras
et
al
howev
abil
releas
pufa
vivo
result
pathophysiolog
outcom
taken
consider
focu
mainli
establish
role
specif
tissu
enzym
endogen
express
substanti
level
drive
lipid
metabol
sever
studi
demonstr
express
pulmonari
epitheli
cell
although
much
lower
level
gi
tract
testi
perhap
asthma
beststudi
diseas
exert
proinflammatori
function
aa
metabol
mice
show
resist
antigeninduc
asthma
mark
reduct
eosinophil
infiltr
goblet
cell
hyperplasia
smooth
muscl
layer
thicken
pulmonari
eicosanoid
synthesi
henderson
et
al
attenu
asthmat
respons
mice
restor
knockin
human
gene
treatment
knockin
mice
inhibitor
specif
human
attenu
pulmonari
inflamm
unlik
see
earlier
howev
influenc
respons
sinc
ige
level
unaffect
mice
henderson
et
al
mechanist
secret
airway
epithelium
may
act
infiltr
eosinophil
paracrin
manner
trigger
lpcdepend
activ
cpla
ltc
biosynthesi
hallstrand
et
al
lai
et
al
select
inhibit
attenu
fmlpinduc
releas
aa
ltc
human
eosinophil
suggest
autocrin
amplif
aa
metabol
coordin
action
eosinophilsecret
intracellular
cpla
hallstrand
et
al
addit
induc
vitro
differenti
airway
epitheli
cell
appear
elicit
aa
releas
directli
hallstrand
et
al
mice
also
partial
protect
earli
phase
lung
inflamm
follow
influenza
infect
kelvin
et
al
moreov
major
spla
isoform
detect
airway
patient
asthma
hallstrand
et
al
thu
asthmat
spla
may
novel
therapeut
target
asthma
inflammatori
diseas
airway
contrari
propos
promot
inflamm
mice
display
strike
immunosuppress
lean
phenotyp
lymphopenia
increas
macrophag
muras
et
al
phenotyp
accompani
mark
elev
antiinflammatori
pufa
metabolit
multipl
tissu
indic
first
time
capac
releas
pufa
vivo
effort
obtain
physiolog
insight
phenomenon
studi
use
mice
demonstr
endogen
express
abundantli
colon
epithelium
gastrointestin
spla
mobil
pufa
metabolit
rather
aa
metabolit
therebi
protect
tissu
dextran
sulfat
dss
induc
coliti
muras
et
al
defici
increas
colorect
express
cytokin
pufa
attenu
product
cytokin
lamina
propria
cell
dsstreat
mice
least
part
pufa
receptor
comparison
product
colonprotect
prostanoid
pge
kabashima
et
al
regul
mainli
cpla
muras
et
al
result
underscor
previous
unappreci
role
pufa
mobil
vivo
segreg
mobil
pufa
cpla
respect
protect
coliti
function
connect
particular
spla
pufasens
receptor
fig
b
herein
overview
sever
phenotyp
mice
context
cardiovascular
metabol
diseas
although
conflict
result
report
mice
protect
myocardi
infarct
aneurysm
fujioka
et
al
watanab
et
al
zack
et
al
differ
group
report
opposit
promot
protect
atherosclerot
phenotyp
mice
aitoufella
et
al
zack
et
al
human
report
gene
polymorph
neg
correl
risk
recurr
cardiovascular
event
associ
risk
gora
et
al
guardiola
et
al
mice
display
increas
reduc
adipos
li
shrida
forrest
bailey
webb
sato
et
al
alter
unalt
macrophag
function
increas
adren
steroidogenesi
probabl
pufamedi
perturb
nuclear
receptor
signal
alter
insulin
secret
pancreat
cell
perhap
due
reduc
pge
synthesi
shrida
zahoor
forrest
layn
webb
express
abundantli
gut
epithelium
decreas
digest
dietari
biliari
phospholipid
may
eventu
associ
reduc
adipos
mice
situat
similar
mice
see
later
altern
gi
tract
might
alter
microbiota
could
secondarili
affect
immun
metabol
balanc
ley
et
al
mazmanian
liu
tzianabo
kasper
tremaroli
backh
could
explain
discrep
observ
mice
maintain
differ
facil
although
requir
experiment
confirm
apart
immunolog
consider
prefer
pufa
also
observ
spermatozoa
anoth
site
spla
highli
express
secret
sperm
acrosom
act
sperm
membran
mobil
dpa
dha
former
promot
abil
spermatozoa
fertil
oocyt
escoffi
et
al
muras
et
al
sato
et
al
dssinduc
coliti
cpla
suppress
intestin
inflamm
cpla
coupl
aaderiv
pge
axi
coupl
axi
cox
cyclooxygenas
lox
lipoxygenas
mpge
microsom
pge
synthas
tx
thromboxan
synthas
pge
receptor
acid
second
ltb
receptor
b
schemat
model
role
protect
coliti
preferenti
releas
pufa
damag
epitheli
cell
pufa
metabol
resolvin
prevent
proinflammatori
immun
respons
probabl
act
directli
epitheli
cell
protect
injuri
neutrophil
suppress
migrat
promot
clearanc
overview
spla
whose
role
immun
vivo
well
understood
also
briefli
describ
integr
membran
protein
bind
convent
spla
spla
spla
ib
prototyp
isoform
often
refer
pancreat
spla
secret
pancreat
acinar
cell
intestin
lumen
ntermin
heptapeptid
zymogen
cleav
trypsin
yield
activ
enzym
seilham
randal
yamanaka
johnson
verheij
westerman
sternbi
de
haa
although
immunolog
function
unknown
mice
refractori
dietinduc
metabol
disord
atherosclerosi
holli
hui
holli
konaniah
goodin
hui
huggin
boileau
hui
labont
et
al
suggest
absenc
may
indirectli
amelior
metabol
inflamm
phenotyp
mice
like
explain
reduc
digest
dietari
biliari
phospholipid
gi
tract
huggin
et
al
accordingli
reduc
product
absorpt
lpc
gi
tract
causal
factor
insulin
resist
lead
protect
metabol
disord
holli
hui
holli
et
al
labont
et
al
hand
pancreat
acinar
cellspecif
mice
develop
sever
obes
insulin
intoler
cash
et
al
oral
administr
cellimperm
panspla
inhibitor
mice
attenu
dietinduc
obes
diabet
inhibit
probabl
gi
tract
hui
et
al
thu
pharmacolog
inhibit
digest
spla
could
effect
oral
therapi
metabol
diseas
spla
iic
member
group
ii
spla
uniqu
extra
sequenc
middl
region
molecul
express
abundantli
rodent
testi
chen
et
al
howev
sinc
spla
pseudogen
express
function
protein
human
tischfield
et
al
analysi
mice
conduct
nonetheless
relat
immun
knockdown
studi
demonstr
induc
mous
hepatocyt
infect
hepat
b
produc
lpe
lysophospholipid
antigen
lpe
present
nkt
cell
lead
propag
antiviru
immun
respons
zeissig
et
al
remain
unknown
whether
spla
may
compens
function
human
hepatocyt
spla
iie
like
structur
homolog
valentin
ghomashchi
et
al
anoth
metabol
spla
markedli
induc
adipocyt
obes
mice
mice
modestli
protect
dietinduc
obes
fatti
liver
hyperlipidemia
without
accompani
alter
adipos
tissu
inflamm
mechanist
hydrolyz
minor
lipoprotein
phospholipid
pe
ps
therebi
affect
lipoproteinmedi
lipid
deliveri
adipos
tissu
liver
unlik
situat
mice
howev
rather
highli
express
human
rat
adipos
tissu
might
act
place
inde
administr
inhibitor
rat
prevent
metabol
disord
iyer
et
al
human
polymorph
gene
associ
ulcer
coliti
yang
et
al
lastli
spla
xiia
xiib
respect
belong
atyp
group
xii
spla
subfamili
uniqu
structur
function
featur
rouault
bolling
lazdunski
gelb
lambeau
far
report
immunolog
role
spla
vivo
interestingli
kill
gramneg
bacteria
helicobact
pylori
even
effici
vitro
huhtinen
et
al
koduri
et
al
suggest
potenti
role
host
defens
defici
catalyt
inact
isoform
activ
center
replac
leu
rouault
et
al
lead
reduc
secret
verylowdens
lipoprotein
liver
guan
qu
tan
chen
wong
although
mechan
underli
phenotyp
entir
unclear
also
known
belong
ctype
lectin
famili
bind
sever
convent
spla
distinct
affin
speciesspecif
manner
rouault
et
al
may
act
clearanc
receptor
inactiv
spla
signal
receptor
transduc
spla
depend
signal
catalyt
activityindepend
manner
pleiotrop
receptor
bind
nonspla
ligand
allergeninduc
asthma
lung
mice
display
advanc
inflamm
accompani
greater
accumul
protein
tamaru
et
al
provid
first
vivo
evid
serv
clearanc
receptor
spla
myocardi
infarct
mice
exhibit
higher
rate
cardiac
ruptur
myofibroblast
activ
mishina
et
al
interact
integrin
may
transmit
spla
depend
signal
augment
myofibroblastdriven
wound
heal
may
facilit
clearanc
offens
spla
eg
mice
higher
suscept
skin
tumorigenesi
vindrieux
et
al
may
base
spla
independ
function
senesc
impair
clearanc
skinresid
offens
spla
eg
final
major
autoantigen
membran
nephropathi
sever
autoimmun
diseas
lead
podocyt
injuri
proteinuria
beck
et
al
stanescu
et
al
howev
clear
whether
role
express
podocyt
spla
depend
independ
whether
spla
play
role
glomerulu
suppli
circul
mesangi
cell
known
secret
inflammatori
condit
beck
et
al
studi
last
decad
uncov
pathophysiolog
function
nearli
full
set
spla
individu
spla
play
uniqu
tissuespecif
role
drive
canon
aa
metabol
noncanon
lipid
pathway
immunolog
metabol
cancer
biolog
event
hydrolyz
differ
phospholipid
compon
variou
extracellular
milieu
nonetheless
sinc
present
knowledg
function
spla
base
result
studi
use
knockout
andor
transgen
mice
import
translat
find
human
associ
spla
human
diseas
relationship
phenotyp
seen
spla
genemanipul
mice
summar
tabl
hope
next
decad
gain
comprehens
pictur
spla
driven
lipid
network
thu
allow
therapeut
applic
inhibitor
spla
spla
driven
lipid
product
human
diseas
kugiyama
et
al
n
